Analyze Diet
Journal of clinical microbiology1982; 15(2); 324-329; doi: 10.1128/jcm.15.2.324-329.1982

Identification of immunoglobulin heavy-chain isotypes of specific antibodies of horse 46 group B meningococcal antiserum.

Abstract: Hyperimmune horse serum from a single animal (horse 46) immunized with group B (strain B-11) meningococcal vaccine provides a standardized, readily available diagnostic reagent used in primary isolation medium and for serogrouping of meningococci. Identification of the heavy-chain isotypes of specific anticapsular polysaccharide and anti-lipopolysaccharide isolated from horse 46 serum revealed a differential distribution in the occurrence of immunoglobulin classes. Meningococcal anticapsular antibodies of horse 46 serum were restricted predominately to the immunoglobulin M (IgM) class, with only trace amounts of IgGa present, whereas anti-lipopolysaccharide concomitantly produced showed a heterogeneity in its heavy-chain isotypes, consisting of IgM, IgGa, IgGb, moderate amounts of IgB, and a small amount of IgA.
Publication Date: 1982-02-01 PubMed ID: 6802867PubMed Central: PMC272085DOI: 10.1128/jcm.15.2.324-329.1982Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article discusses the identification of different types of immunoglobulin heavy-chain isotypes in horse 46 which was injected with group B meningococcal vaccine. It was observed that the presence of different classes of immunoglobulins varied based on the type of antibodies targeted.

Immunoglobulin Isotypes in Hyperimmune Horse Serum

  • In the research, serum from a single horse, termed horse 46, was used. The horse was immunized with a group B meningococcal vaccine to produce a hyperimmune serum. This serum served as a diagnostic tool in the identification and isolation of meningococci, a bacterium responsible for meningitis and septicemia.

Antibodies and Associated Heavy-Chain Isotypes

  • Two main types of antibodies isolated from the horse 46 serum were anticapsular polysaccharide and anti-lipopolysaccharide.
  • The study found that anticapsular polysaccharide antibodies were predominantly related to the immunoglobulin M (IgM) class, with only trace amounts of immunoglobulin Ga (IgGa) present.
  • Unlike anticapsular antibodies, anti-lipopolysaccharide antibodies showed a mixture of heavy-chain isotypes, including IgM, IgGa, immunoglobulin Gb (IgGb), moderate amounts of immunoglobulin B (IgB), and a small amount of immunoglobulin A (IgA).

Significance of the Research

  • The differential occurrence of immunoglobulin classes in the hyperimmune horse serum gives new insights into understanding the immune response of horses to meningococcal infections. This knowledge may inform the development of more effective vaccines and diagnostic tests for this dangerous disease.

Cite This Article

APA
Allen PZ, Glode M, Schneerson R, Robbins JB. (1982). Identification of immunoglobulin heavy-chain isotypes of specific antibodies of horse 46 group B meningococcal antiserum. J Clin Microbiol, 15(2), 324-329. https://doi.org/10.1128/jcm.15.2.324-329.1982

Publication

ISSN: 0095-1137
NlmUniqueID: 7505564
Country: United States
Language: English
Volume: 15
Issue: 2
Pages: 324-329

Researcher Affiliations

Allen, P Z
    Glode, M
      Schneerson, R
        Robbins, J B

          MeSH Terms

          • Animals
          • Antibodies, Bacterial / isolation & purification
          • Chromatography, Gel
          • Horses / immunology
          • Immune Sera / analysis
          • Immunization
          • Immunodiffusion
          • Immunoglobulin Heavy Chains / isolation & purification
          • Neisseria meningitidis / immunology

          References

          This article includes 18 references
          1. J Exp Med. 1967 Feb 1;125(2):249-75
            pubmed: 4959973
          2. J Infect Dis. 1970 Jul-Aug;122(1):100-3
            pubmed: 4988472
          3. J Immunol. 1970 Nov;105(5):1253-63
            pubmed: 4099925
          4. J Biol Chem. 1971 Aug 10;246(15):4703-12
            pubmed: 4327325
          5. J Immunol. 1973 Jan;110(1):262-8
            pubmed: 4346607
          6. Immunochemistry. 1973 Jun;10(6):365-71
            pubmed: 4200124
          7. N Engl J Med. 1974 May 30;290(22):1216-20
            pubmed: 4133095
          8. J Biol Chem. 1975 Mar 10;250(5):1926-32
            pubmed: 163259
          9. J Immunol. 1975 Jan;114(1 Pt 1):99-101
            pubmed: 803530
          10. Immunology. 1975 Jan;28(1):187-97
            pubmed: 1116869
          11. Lancet. 1975 May 17;1(7916):1099-104
            pubmed: 49468
          12. Acta Pathol Microbiol Scand B. 1977 Feb;85B(1):103-7
            pubmed: 65900
          13. Immunochemistry. 1977 Mar;14(3):161-4
            pubmed: 16825
          14. Infect Immun. 1977 Apr;16(1):75-80
            pubmed: 326679
          15. J Clin Pathol. 1977 Sep;30(9):834-7
            pubmed: 410847
          16. J Clin Microbiol. 1978 May;7(5):410-4
            pubmed: 96123
          17. J Exp Med. 1979 Mar 1;149(3):669-85
            pubmed: 372481
          18. J Clin Microbiol. 1980 Oct;12(4):498-501
            pubmed: 6775011